caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1669420956

Teresa De MarcoMD

PRACTICEUCSFSee all providers at this practice →
CardiologySan Francisco, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Teresa De Marco's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 12 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Gordon Fung
Cardiology · San Francisco, CA
69274
Liviu Klein
Cardiology · San Francisco, CA
65449
Munir Janmohamed
Advanced Heart Failure and Transplant Cardiology · Sacramento, CA
50409
Van Selby
Internal Medicine · San Francisco, CA
40407
Nimaljeet Tarango
Nurse Practitioner · San Francisco, CA
2064
Nelson Schiller
Cardiology · San Francisco, CA
1851
URSELL, PHILIP17220
RAO, RAJNI1643
NPI 14876941211583
WIESELTHALER, GEORG14467
Tara Morgan
Diagnostic Radiology · Stanford, CA
1368
Liina Poder
Diagnostic Radiology · San Francisco, CA
1240
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
209
Unique beneficiaries
—
Total services
470
Distinct HCPCS
5
Medicare payment
$34K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,869 Cardiology providers in CA — below median (cohort median 2,371).
PRESCRIBING · PART D · 2024
Total Rx claims
479
Beneficiaries
—
Total drug cost
$2.0M
Distinct drugs
21
Brand share
30.5%
Top prescribed drugs
Macitentan41 claims
Ambrisentan39 claims
Carvedilol36 claims
Selexipag36 claims
Hydralazine Hcl33 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
95.0
Cost
80.6
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
1.05%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$83K
Payment records
58
By payment type
Consulting Fee$77K
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$3K
Travel and Lodging$1K
Food and Beverage$1K